Synaptogenix, Inc. (SNPX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	S-1/A	S-1
Revenues	0.0	0.0	0.0	5.7	4.6
Revenue growth			-100.0%	22.6%
Cost of goods sold	0.0	0.0	0.0	15.5	11.1
Gross profit	0.0	0.0	0.0	-9.8	-6.5
Gross margin				-173.6%	-141.1%
Selling, general and administrative [+]	9.8	8.3	8.1	9.6	4.0
General and administrative	9.8	8.3	8.1	9.6	4.0
Research and development	6.3	4.3	3.1
Other operating expenses	-19.2	-25.2	-27.0	-34.2	7.2
EBITDA [+]	3.1	12.6	15.8	14.8	-17.7
EBITDA growth	-75.5%	-20.2%	7.1%	-183.5%
EBITDA margin				260.3%	-382.2%
Depreciation and amortization	0.0	0.0	0.0	0.0	0.0
EBIT [+]	3.1	12.6	15.8	14.8	-17.7
EBIT growth	-75.5%	-20.3%	7.1%	-183.5%
EBIT margin				260.2%	-382.3%
Interest income	0.3	0.0	0.2	0.4
Interest income	0.3	0.0	0.2	0.4
Other income (expense), net [+]	2.2	0.0	-3.2		28.7
Gain (loss) on derivative instruments	1.8
Change in fair value of warrants	8.4		1.7
Pre-tax income	5.6	12.6	12.7	15.1	11.0
Income taxes	11.1	25.2	0.0	0.0	0.0
Tax rate	200.0%	200.0%	0.0%	0.0%	0.0%
Net income	5.7	12.6	15.1	15.1	11.0
Net margin				266.9%	238.4%

Basic EPS [+]	$0.81	$2.51	$12.03	$3.01	$1.37
Growth	-67.6%	-79.1%	299.9%	119.8%
Diluted EPS [+]	$0.81	$2.51	$12.03	$3.01	$1.37
Growth	-67.6%	-79.1%	299.9%	119.8%

Shares outstanding (basic) [+]	7.0	5.0	1.3	5.0	8.1
Growth	39.4%	298.8%	-75.0%	-37.5%
Shares outstanding (diluted) [+]	7.0	5.0	1.3	5.0	8.1
Growth	39.4%	298.8%	-75.0%	-37.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.